vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and GRID DYNAMICS HOLDINGS, INC. (GDYN). Click either name above to swap in a different company.
GRID DYNAMICS HOLDINGS, INC. is the larger business by last-quarter revenue ($104.1M vs $83.5M, roughly 1.2× BillionToOne, Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs -1.4%, a 8.3% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 3.7%).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.
BLLN vs GDYN — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $104.1M |
| Net Profit | $5.7M | $-1.5M |
| Gross Margin | 69.9% | 34.8% |
| Operating Margin | 11.5% | 61.7% |
| Net Margin | 6.8% | -1.4% |
| Revenue YoY | 117.4% | 3.7% |
| Net Profit YoY | 138.3% | -150.6% |
| EPS (diluted) | $0.10 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $104.1M | ||
| Q4 25 | — | $106.2M | ||
| Q3 25 | $83.5M | $104.2M | ||
| Q2 25 | — | $101.1M | ||
| Q1 25 | — | $100.4M | ||
| Q4 24 | — | $100.3M | ||
| Q3 24 | $38.4M | $87.4M | ||
| Q2 24 | — | $83.0M |
| Q1 26 | — | $-1.5M | ||
| Q4 25 | — | $306.0K | ||
| Q3 25 | $5.7M | $1.2M | ||
| Q2 25 | — | $5.3M | ||
| Q1 25 | — | $2.9M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | $-14.9M | $4.3M | ||
| Q2 24 | — | $-817.0K |
| Q1 26 | — | 34.8% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | 69.9% | 33.3% | ||
| Q2 25 | — | 34.1% | ||
| Q1 25 | — | 36.8% | ||
| Q4 24 | — | 36.9% | ||
| Q3 24 | 52.6% | 37.4% | ||
| Q2 24 | — | 35.6% |
| Q1 26 | — | 61.7% | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | 11.5% | -0.2% | ||
| Q2 25 | — | -0.1% | ||
| Q1 25 | — | -2.0% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | -32.9% | 2.4% | ||
| Q2 24 | — | 0.0% |
| Q1 26 | — | -1.4% | ||
| Q4 25 | — | 0.3% | ||
| Q3 25 | 6.8% | 1.1% | ||
| Q2 25 | — | 5.2% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | — | 4.5% | ||
| Q3 24 | -38.8% | 4.9% | ||
| Q2 24 | — | -1.0% |
| Q1 26 | — | $-0.02 | ||
| Q4 25 | — | $0.01 | ||
| Q3 25 | $0.10 | $0.01 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | — | $0.03 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | $-1.47 | $0.05 | ||
| Q2 24 | — | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $327.5M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $530.1M |
| Total Assets | $327.5M | $605.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $327.5M | ||
| Q4 25 | — | $342.1M | ||
| Q3 25 | $195.2M | $338.6M | ||
| Q2 25 | — | $336.8M | ||
| Q1 25 | — | $325.5M | ||
| Q4 24 | — | $334.7M | ||
| Q3 24 | — | $231.3M | ||
| Q2 24 | — | $256.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $530.1M | ||
| Q4 25 | — | $542.1M | ||
| Q3 25 | $-239.5M | $537.7M | ||
| Q2 25 | — | $532.2M | ||
| Q1 25 | — | $517.4M | ||
| Q4 24 | — | $517.8M | ||
| Q3 24 | $-242.9M | $400.2M | ||
| Q2 24 | — | $388.4M |
| Q1 26 | — | $605.0M | ||
| Q4 25 | — | $612.9M | ||
| Q3 25 | $327.5M | $613.2M | ||
| Q2 25 | — | $608.9M | ||
| Q1 25 | — | $590.9M | ||
| Q4 24 | — | $592.2M | ||
| Q3 24 | — | $477.3M | ||
| Q2 24 | — | $443.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | — |
| Free Cash FlowOCF − Capex | $6.5M | — |
| FCF MarginFCF / Revenue | 7.7% | — |
| Capex IntensityCapex / Revenue | 8.8% | — |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $9.9M | ||
| Q3 25 | $13.8M | $7.0M | ||
| Q2 25 | — | $14.4M | ||
| Q1 25 | — | $9.4M | ||
| Q4 24 | — | $7.1M | ||
| Q3 24 | — | $9.2M | ||
| Q2 24 | — | $10.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $6.1M | ||
| Q3 25 | $6.5M | $2.9M | ||
| Q2 25 | — | $10.2M | ||
| Q1 25 | — | $6.0M | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | — | $5.9M | ||
| Q2 24 | — | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.7% | ||
| Q3 25 | 7.7% | 2.8% | ||
| Q2 25 | — | 10.1% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 9.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.6% | ||
| Q3 25 | 8.8% | 3.9% | ||
| Q2 25 | — | 4.1% | ||
| Q1 25 | — | 3.3% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 3.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 32.34× | ||
| Q3 25 | 2.42× | 5.92× | ||
| Q2 25 | — | 2.73× | ||
| Q1 25 | — | 3.21× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | — | 2.15× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
GDYN
Segment breakdown not available.
